Epidemiological risk factors associated with inflammatory breast cancer subtypes

Cancer Causes & Control : CCC
Rachel L AtkinsonAbenaa Brewster

Abstract

In this single-institution case-control study, we identified risk factors associated with inflammatory breast cancer (IBC) subtypes based on staining of estrogen receptor (ER), progesterone receptor (PR) and expression of human epidermal growth factor 2 (HER2neu) to determine distinct etiologic pathways. We identified 224 women with IBC and 396 cancer-free women seen at the MD Anderson Cancer Center. Multinomial logistic regression was used to estimate odds ratios (ORs) and 95 % confidence intervals (CIs) for associations between breast cancer risk factors and the IBC tumor subtypes: luminal (ER+ and/or PR+/HER2neu-), HER2neu+ (any ER and PR, HER2neu+), and triple-negative (ER-/PR-/HER2neu-). In multivariable analysis, compared with women age ≥26 at first pregnancy, women age <26 had a higher risk of triple-negative IBC (OR 3.32, 95% CI 1.37-8.05). Women with a history of breast-feeding had a lower risk of triple-negative (OR 0.30; 95% CI 0.15-0.62) and luminal IBC (OR 0.35, 95% CI 0.18-0.68). A history of smoking was associated with an increased risk of luminal IBC (OR 2.37; 95% CI 1.24-4.52). Compared with normal-weight women, those who were overweight or obese (body mass index ≥25 kg/m(2)) had a higher risk of all three tumo...Continue Reading

References

Dec 16, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S ChangS D Hursting
Aug 30, 2000·Nature·C M PerouD Botstein
Sep 13, 2001·Proceedings of the National Academy of Sciences of the United States of America·T SørlieA L Børresen-Dale
Oct 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jennifer A LowSandra M Swain
Oct 4, 2005·The Breast : Official Journal of the European Society of Mastology·Monique G LêCarole Rubino
Mar 21, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Xiaohong R YangMontserrat García-Closas
Jun 21, 2007·Breast Cancer Research and Treatment·Robert C MillikanCharles M Perou
Apr 4, 2009·Cancer Causes & Control : CCC·Katrina F TriversJ William Eley
May 26, 2009·Breast Cancer Research : BCR·Marilyn L KwanBette J Caan
Sep 1, 2009·Preventive Medicine·Noémie TravierPetra H Peeters
Jul 7, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S DawoodM Cristofanilli
Dec 15, 2010·Breast Cancer Research and Treatment·Takayuki IwamotoNaoto T Ueno
Dec 31, 2010·Journal of the National Cancer Institute·Takayuki IwamotoLajos Pusztai
May 31, 2011·Cancer Prevention Research·Patrick G MorrisAndrew J Dannenberg
Oct 18, 2011·Breast Cancer Research and Treatment·Xuezheng SunMelissa A Troester
Jan 19, 2012·JAMA : the Journal of the American Medical Association·Katherine M FlegalCynthia L Ogden
Sep 18, 2012·The Breast : Official Journal of the European Society of Mastology·Fatma P TurkozKadri Altundag
Feb 12, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Steven J Van LaereFrançois Bertucci
May 8, 2013·American Journal of Clinical Oncology·Chiaojung Jillian TsaiThomas A Buchholz
Sep 21, 2013·Journal of the National Cancer Institute·Catherine SchairerDiana L Miglioretti
Jan 31, 2014·Breast Cancer Research and Treatment·Kristin N AndersonMaria Elena Martinez
Jul 23, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Felipe AdesMartine Piccart
Oct 28, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F IslamiM Weiss

❮ Previous
Next ❯

Citations

Jul 12, 2016·The Breast : Official Journal of the European Society of Mastology·Francisco AcevedoCésar Sánchez
May 17, 2018·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Dagmar HorakovaHelena Kollarova
Sep 4, 2017·Environmental Health : a Global Access Science Source·Janet M GrayJeanne Rizzo
Aug 2, 2017·CA: a Cancer Journal for Clinicians·Manuel Picon-RuizJoyce M Slingerland
Sep 3, 2020·Breast Cancer Research and Treatment·Catherine SchairerAmr S Soliman
May 14, 2020·Cells·Flavia Lima Costa FaldoniSilvia Regina Rogatto
Jul 22, 2020·Breast Cancer Research and Treatment·Catherine SchairerLawrence H Kushi
Jul 8, 2020·Cancers·Ryan Kolb, Weizhou Zhang
Jan 1, 2017·Expert Review of Endocrinology & Metabolism·Pamela J Goodwin
Jun 3, 2018·Breast Cancer Research and Treatment·Jay P ReddyWendy A Woodward
Jan 13, 2019·Cancers·Sebastiano AndòStefania Catalano
Sep 8, 2017·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Merete Ellingjord-DaleGiske Ursin
Jun 15, 2021·Breast Disease·Paul H Levine, Carmela C Veneroso
Jul 31, 2021·Cancer Medicine·Wintana BalemaWendy A Woodward
Nov 25, 2021·Cancer Causes & Control : CCC·Marta Hernández-GarcíaDolores Salas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.